What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Bacteria
Her main research concerns Microbiology, Mycobacterium abscessus, Internal medicine, Nontuberculous mycobacteria and Mycobacterium fortuitum.
Her Microbiology study combines topics from a wide range of disciplines, such as Nocardia, Mycobacterium and Mycobacterium pseudoshottsii.
Barbara A. Brown-Elliott does research in Mycobacterium abscessus, focusing on Mycobacterium massiliense specifically.
Her Internal medicine research includes themes of Surgery, Azithromycin, Clarithromycin, Sputum and Drug resistance.
Her studies examine the connections between Nontuberculous mycobacteria and genetics, as well as such issues in Mycobacterium avium-intracellulare infection, with regards to Lymphatic disease, Disseminated disease, Disease, Mycobacterium haemophilum and Bedaquiline.
Her work focuses on many connections between Mycobacterium fortuitum and other disciplines, such as Mycobacterium chelonae, that overlap with her field of interest in Ribosomal RNA, Mycobacterium immunogenum and Mycobacterium wolinskyi.
Her most cited work include:
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases (3776 citations)
- Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes (901 citations)
- Clinical and Laboratory Features of the Nocardia spp. Based on Current Molecular Taxonomy (672 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Microbiology, Nontuberculous mycobacteria, Mycobacterium, Mycobacterium abscessus and Amikacin.
Her study in Microbiology is interdisciplinary in nature, drawing from both Nocardia, Mycobacterium chelonae, 16S ribosomal RNA and Mycobacterium fortuitum.
She usually deals with Nontuberculous mycobacteria and limits it to topics linked to Mycobacterium avium-intracellulare infection and Bedaquiline.
Her work on Mycobacterium massiliense is typically connected to Confusion as part of general Mycobacterium abscessus study, connecting several disciplines of science.
Her research in Amikacin intersects with topics in Clarithromycin and Internal medicine, Surgery, Refractory.
Intensive care is closely connected to Ethambutol in her research, which is encompassed under the umbrella topic of Internal medicine.
She most often published in these fields:
- Microbiology (59.26%)
- Nontuberculous mycobacteria (26.85%)
- Mycobacterium (25.93%)
What were the highlights of her more recent work (between 2016-2021)?
- Microbiology (59.26%)
- Nontuberculous mycobacteria (26.85%)
- Amikacin (17.59%)
In recent papers she was focusing on the following fields of study:
Barbara A. Brown-Elliott mainly investigates Microbiology, Nontuberculous mycobacteria, Amikacin, Mycobacterium and Mycobacterium abscessus.
Her work on Antimicrobial susceptibility as part of general Microbiology study is frequently connected to Linezolid, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Barbara A. Brown-Elliott interconnects Mycobacterium Infections, Clinical disease and Drug resistance in the investigation of issues within Antimicrobial susceptibility.
Her studies in Nontuberculous mycobacteria integrate themes in fields like Mycobacterium fortuitum, Tigecycline, Mycobacterium tuberculosis, Mass spectrometry and DNA sequencing.
Barbara A. Brown-Elliott has researched Mycobacterium abscessus in several fields, including Evolutionary biology and Nomenclature.
Her Nocardia research is multidisciplinary, incorporating perspectives in Multiple drug resistance, Adverse effect and Aminoglycoside resistance.
Between 2016 and 2021, her most popular works were:
- Rapidly Growing Mycobacteria. (50 citations)
- In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria (42 citations)
- Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease. (37 citations)
In her most recent research, the most cited papers focused on:
- Bacteria
- Gene
- Internal medicine
Her primary scientific interests are in Nontuberculous mycobacteria, Microbiology, Mycobacterium, Bedaquiline and Mycobacterium tuberculosis.
The concepts of her Nontuberculous mycobacteria study are interwoven with issues in Clarithromycin, Amikacin, Susceptibility testing and DNA sequencing.
Her Clarithromycin research includes themes of Antimycobacterial, Tigecycline, Moxifloxacin and Mycobacterium abscessus.
Barbara A. Brown-Elliott combines subjects such as 16S ribosomal RNA and Mycobacterium fortuitum with her study of Microbiology.
Her Mycobacterium colombiense study in the realm of Mycobacterium connects with subjects such as Whole genome sequencing.
Her work carried out in the field of Mycobacterium tuberculosis brings together such families of science as In vitro, Subspecies, Nocardia species, Nocardia and Mass spectrometry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
